leadf
logo-loader
viewIXICO PLC

IXICO to supply its imaging expertise to leading Alzheimer’s trial

The UK group will collect and analyse Positron Emission Tomography images generated by the Global Alzheimer's Platform Foundation’s Bio-Hermes study

IXICO PLC -

IXICO PLC (LON:IXI) has been selected to provide its brain scan expertise to a trial being conducted by a leading network of Alzheimer’s research institutions.

The UK group will collect and analyse positron emission tomography images generated by the Global Alzheimer's Platform Foundation’s (GAP) Bio-Hermes study.

Its main purpose is the development of a database to investigate biomarkers on a head-to-head basis in conjunction with medical history elements.

The trial will include 1,000 volunteers over the age of 60 screened for pre-clinical Alzheimer's as well as prodromal and mild dementia forms of the disease.

Earlier assessments of the condition consistently suggest a build-up of beta-amyloid and tau proteins as well neurofibrillary tangles are “sentinel events” in Alzheimer's.

IXICO said the contract will “contribute to the company's already strong year-end order book”.

In a statement, IXICO's chief executive Giulio Cerroni noted: "With a reinvigorated level of interest in Alzheimer's Disease, we are excited about the prospects of a long-term collaboration with our colleagues at GAP who share our own commitment to reducing the time, cost, and risk for Alzheimer's Disease trials.

“The support provided by IXICO staff on Bio-Hermes is an important commercial development in enhancing IXICO's market position in neuroimaging for Alzheimer's Disease clinical trials."

Quick facts: IXICO PLC

Price: 106.5 GBX

AIM:IXI
Market: AIM
Market Cap: £50.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

IXICO revenues' rise for fourth consecutive year, up by 26%

IXICO PLC's (LON:IXI) Giulio Cerroni talks to Proactive London about his artificial intelligence-driven data analytics company. Cerroni explains the latest set of results, which show revenue rose by 26% to £9.5m, up from £7.6m the year before. He also highlights the order book which grew...

3 days, 20 hours ago

2 min read